ArticleNeurobiology of disease2025
Cortical beta power modulation is asymmetric and reduced during movement execution and inhibition in Parkinson's disease.
Article in Neurobiology of disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bidirectional EEG Neurofeedback of Sensorimotor Beta Oscillations Reveals Asymmetric Modulation and Strategy-Dependent Learning.The European journal of neuroscience · 2026Article
- The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Inability to initiate movements is a cardinal feature of Parkinson's disease (PD), but inhibitory motor control is also impaired. Cortical electrophysiologic spectral patterns of these processes are still poorly understood. We investigated cortical electrophysiology during movement planning, execution and proactive inhibition in patients with PD. We hypothesized that in the healthy state, proactive inhibition is accompanied by increased beta band activity in the right frontal cortex, and that this process is impaired in PD patients. We recorded 64-channel EEG in 20 moderately advanced PD patients, off and on levodopa, and 20 age-matched healthy controls during cued Go and Go/NoGo tasks and performed spectral time-frequency analysis. PD patients exhibited prolonged response times, more errors and altered cortical activity patterns compared to controls. Levodopa improved movement execution in a simple Go task, but impaired proactive inhibition in a more complex Go/NoGo task. Spectral EEG analysis during movement planning and execution (Go task) showed reduced beta power modulation in PD patients particularly in the more impaired hemisphere, off and on levodopa. When proactive inhibition was engaged (Go/NoGo task), beta power over the right lateral frontal cortex was higher (i.e. decreased less compared to Go task) in healthy controls than in PD patients on medications. In conclusion, PD patients exhibit decreased and asymmetric beta power modulation over the sensorimotor cortex during movement. Proactive inhibition is associated with elevated beta activity over the right lateral frontal cortex in healthy controls, and this pattern is attenuated in PD patients in conjunction with a behavioral inhibitory deficit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.